Roivant Sciences (ROIV) Leases (2021 - 2025)
Roivant Sciences (ROIV) has disclosed Leases for 5 consecutive years, with $83.6 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Leases fell 8.07% year-over-year to $83.6 million, compared with a TTM value of $83.6 million through Dec 2025, down 8.07%, and an annual FY2025 reading of $89.0 million, up 102.31% over the prior year.
- Leases was $83.6 million for Q4 2025 at Roivant Sciences, down from $85.1 million in the prior quarter.
- Across five years, Leases topped out at $90.9 million in Q4 2024 and bottomed at $43.0 million in Q3 2024.
- Average Leases over 5 years is $62.4 million, with a median of $60.2 million recorded in 2022.
- The sharpest move saw Leases fell 17.37% in 2024, then soared 102.31% in 2025.
- Year by year, Leases stood at $61.7 million in 2021, then dropped by 11.42% to $54.6 million in 2022, then decreased by 14.16% to $46.9 million in 2023, then skyrocketed by 93.81% to $90.9 million in 2024, then fell by 8.07% to $83.6 million in 2025.
- Business Quant data shows Leases for ROIV at $83.6 million in Q4 2025, $85.1 million in Q3 2025, and $87.1 million in Q2 2025.